FDA: Medical Mega sells unapproved triclosan antiseptic soaps as nonprescription drugs.
What happened
FDA reviewed Medical Mega's website and found it offered three sizes of Ameriderm AmeriWash Antimicrobial Lotion Soap with Triclosan for sale in the United States. The letter says the products are unapproved new drugs and misbranded because triclosan antiseptic washes are not generally recognized as safe and effective. The website labeling included 'Anti-microbial…Kills bacteria on contact…'
What FDA found
The Ameriderm AmeriWash soaps are unapproved new drugs because FDA has no approved application for them and triclosan antiseptic washes are not generally recognized as safe and effective.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d); section 505G(a)(5), 21 U.S.C. 355h(a)(5)The soaps are misbranded (illegally labeled) because they are nonprescription drugs under section 505G but do not meet its requirements and lack an approved application.
FD&C Act section 502(ee), 21 U.S.C. 352(ee); sections 301(a), 21 U.S.C. 331(a)Website labeling such as 'Kills bacteria on contact' shows the products are intended as drugs.
21 CFR 201.128; FD&C Act section 201(g)(1)(B)-(C), 21 U.S.C. 321(g)(1)(B)-(C)
What FDA wants
FDA asks Medical Mega to notify it in writing within 15 working days of receipt about specific corrective steps, how recurrence will be prevented, and related documentation. If correction cannot be completed in that time, the company must state why and when it will finish.
Who should pay attention
- retailers and distributors selling Medical Mega products
- health care facilities buying antiseptic soaps
- companies marketing OTC antiseptic washes with triclosan
This is a summary. Read the original letter on fda.gov.